Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

Engaging with Regulators for Single-Arm Oncology Research Trials
When well-planned and well-executed, single-arm trials can accelerate access to life-saving therapies that might otherwise never reach desperate cancer patients. read more
Hasty Decisions, Runaway Projects
Despite the best intentions of ISO and EMA, the pharma industry is still largely failing to exploit its data in a strategic, joined-up way - and this could now restrict companies’ ability to capitalize on AI. read more
An Interview With Kim Boericke
Veristat’s new CEO, Kim McLean Boericke, is one step closer to changing the tide in representing the small fraction of companies led by women and is now the only female with the highest job among the top-8 clinical research organizations (CROs). read more
Safely Scaling Highly Potent API manufacturing
Ever more drug developers are searching for CDMOs with contamination-limiting capabilities. But how can they know which have these high-potency credentials? read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

Transcenta Licenses Continuous Bioprocessing Technology to WuXi Biologics
Thursday, September 10, 2026
Transcenta Therapeutics and WuXi Biologics have entered a technology licensing and strategic collaboration agreement covering Transcenta’s HiCB ... read more
CordenPharma Invests $94M to Reach 500M Injectable Units Capacity
Thursday, September 10, 2026
CordenPharma plans to invest €80 million, or about $94 million, over multiple years to expand sterile injectable manufacturing at its Caponago site ... read more
Quva Acquires CAPS 503B Sterile Compounding Product Portfolio
Thursday, September 10, 2026
Quva Pharma has acquired a portfolio of sterile compounded medications from Central Admixture Pharmacy Services, or CAPS, after CAPS decided to exit ... read more
Summit Acquires Dallas Research Institute Through Pinnacle Network
Thursday, September 10, 2026
Summit Clinical Research Solutions has acquired Dallas Research Institute through its Pinnacle Clinical Research site network, expanding its clinical-... read more
Lonza Plans Oregon Spray-Drying Facility for Drug Development, Manufacturing
Thursday, September 10, 2026
Lonza plans to build a commercial-scale spray-drying facility at its Bend, Oregon, site, expanding its capacity to develop and manufacture spray-dried... read more